Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390325
Status:
COMPLETED
Last Update Posted:
2024-02-06
First Post:
2006-10-18
Brief Title:
Sorafenib Tosylate in Treating Patients With Metastatic Locally Advanced or Recurrent Medullary Thyroid Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hereditary Thyroid Gland Medullary Carcinoma |
| Locally Advanced Thyroid Gland Medullary Carcinoma |
| Multiple Endocrine Neoplasia Type 2A |
| Multiple Endocrine Neoplasia Type 2B |
| Recurrent Thyroid Gland Medullary Carcinoma |
| Sporadic Thyroid Gland Medullary Carcinoma |
| Stage III Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IV Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 |
| Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 |
Keywords: